Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Torbenson

Showing results (51-60 of 156) with videos related to

Pageof 16
Sort By:
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 14, 2022
Imaging Features in the Liver after Stereotactic Body Radiation TherapyPatrick J Navin, Michael C Olson, Mishal Mendiratta-Lala, et al.
Human Pathology|October 4, 2017
A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negativeIan Clark, Sejal S Shah, Roger Moreira, et al.
The American Journal of Surgical Pathology|December 20, 2015
Hepatocellular Neoplasms Arising in Association With Androgen UseSounak Gupta, Bita V Naini, Richard Munoz, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
Chronic intermittent hypoxia predisposes to liver injuryVladimir Savransky, Ashika Nanayakkara, Angelica Vivero, et al.
Journal of Clinical Medicine|May 26, 2019
Magnetic Resonance Elastography of Liver in Light Chain AmyloidosisSudhakar K Venkatesh, Safa Hoodeshenas, Sandeep H Venkatesh, et al.
Virchows Archiv : an International Journal of Pathology|June 26, 2020
Ki-67 "hot spot" digital analysis is useful in the distinction of hepatic adenomas and well-differentiated hepatocellular carcinomasAndrea Jones, Trynda N Kroneman, Anthony J Blahnik, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 14, 2007
Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancerMustafa Vali, Eleni Liapi, Jeanne Kowalski, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 29, 2013
Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenomaNancy M Joseph, Linda D Ferrell, Dhanpat Jain, et al.
Hepatology Communications|October 17, 2022
Clinical and demographic predictors of survival for fibrolamellar carcinoma patients-A patient community, registry-based studyAmichai Berkovitz, Rachael D Migler, Adam Qureshi, et al.
Histopathology|August 12, 2015
FGFR1 and FGFR2 in fibrolamellar carcinomaRondell P Graham, Joaquin J Garcia, Patricia T Greipp, et al.
Pageof 16

Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 14, 2022
Imaging Features in the Liver after Stereotactic Body Radiation TherapyPatrick J Navin, Michael C Olson, Mishal Mendiratta-Lala, et al.
Human Pathology|October 4, 2017
A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negativeIan Clark, Sejal S Shah, Roger Moreira, et al.
The American Journal of Surgical Pathology|December 20, 2015
Hepatocellular Neoplasms Arising in Association With Androgen UseSounak Gupta, Bita V Naini, Richard Munoz, et al.
Hepatology (Baltimore, Md.)|March 30, 2007
Chronic intermittent hypoxia predisposes to liver injuryVladimir Savransky, Ashika Nanayakkara, Angelica Vivero, et al.
Journal of Clinical Medicine|May 26, 2019
Magnetic Resonance Elastography of Liver in Light Chain AmyloidosisSudhakar K Venkatesh, Safa Hoodeshenas, Sandeep H Venkatesh, et al.
Virchows Archiv : an International Journal of Pathology|June 26, 2020
Ki-67 "hot spot" digital analysis is useful in the distinction of hepatic adenomas and well-differentiated hepatocellular carcinomasAndrea Jones, Trynda N Kroneman, Anthony J Blahnik, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 14, 2007
Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancerMustafa Vali, Eleni Liapi, Jeanne Kowalski, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 29, 2013
Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenomaNancy M Joseph, Linda D Ferrell, Dhanpat Jain, et al.
Hepatology Communications|October 17, 2022
Clinical and demographic predictors of survival for fibrolamellar carcinoma patients-A patient community, registry-based studyAmichai Berkovitz, Rachael D Migler, Adam Qureshi, et al.
Histopathology|August 12, 2015
FGFR1 and FGFR2 in fibrolamellar carcinomaRondell P Graham, Joaquin J Garcia, Patricia T Greipp, et al.
Pageof 16